NYSE$UHS

Universal Health Services Inc · Q4 2024 earnings

Q4 2024 earnings · · After market close · Investor relations

Briefing

UHS reported strong Q4 2024 earnings with revenue and net income growth across its acute and behavioral health segments.

Universal Health Services, Inc. reported Q4 2024 revenue of $4.11 billion, an increase of 11.1% year-over-year. Net income rose to $332.4 million, while adjusted EPS increased to $4.92. Revenue from acute care and behavioral health services grew by 8.7% and 11.1%, respectively. EBITDA net of NCI improved to $620.2 million, reflecting strong operational performance.

  • Revenue increased 11.1% year-over-year to $4.11 billion.
  • Net income rose 53.6% to $332.4 million, with adjusted EPS at $4.92.
  • EBITDA net of NCI reached $620.2 million, up from $476.9 million in Q4 2023.
  • Acute care and behavioral health revenue grew 8.7% and 11.1%, respectively.

Headline financials

Total Revenue

$4.11B

Previous: $3.7B+11.1%
EPS (adj)

$4.92

Previous: $3.13+57.2%
Avg Licensed Beds

6.8K

Previous: 6.7K+2.6%
Avg Available Beds

6.7K

Previous: 6.5K+2.7%
Patient Days

409.3K

Previous: 403.1K+1.5%
Avg Daily Census

4.4K

Previous: 4.4K+1.5%
Occupancy Licensed Beds

65.0%

Previous: 65.7%-1.1%
Occupancy Available Beds

66.7%

Previous: 67.4%-1.0%
Admissions

85.4K

Previous: 82.9K+3.0%
Length of Stay

4.8

Previous: 4.9-2.0%
BH Avg Licensed Beds

24.1K

Previous: 24.2K-0.5%
BH Avg Available Beds

24.0K

Previous: 24.1K-0.5%
BH Patient Days

1.6M

Previous: 1.6M-1.2%
BH Avg Daily Census

17.2K

Previous: 17.4K-1.2%
BH Occupancy Licensed

71.4%

Previous: 71.9%-0.7%
BH Occupancy Available

71.7%

Previous: 72.2%-0.7%
BH Admissions

114.2K

Previous: 118.5K-3.6%
BH Length of Stay

13.8

Previous: 13.5+2.2%
Capital Expenditures

-$246M

Previous: -$206M-19.2%
Net Income

$332M

Previous: $220M+51.4%
Operating Income

$472M

Previous: $331M+42.7%
Gross Profit

$472M

Previous: $331M+42.7%

Revenue & EPS history

UHS · Revenue · Quarterly

$4.11B

Q4 2024+11.1%vs Q4 2023
Beat estimate in 10 of 15 quarters(67%)
ActualEstimate

Revenue by segment

UHS · $3.56B total across 2 segments · Q3 2023

  • Acute Care Services
    $2.02B+5.1%
  • Behavioral Health Services
    $1.54B+7.5%

Forward guidance

UHS expects continued revenue growth in 2025, driven by strong performance in both acute care and behavioral health segments. The company aims to enhance operational efficiencies while managing labor and expense pressures.

Tailwinds

  • Projected 2025 revenue growth of 7.5% to 9.7% over 2024.
  • Expected Adjusted EBITDA net of NCI between $2.36 billion and $2.48 billion.
  • Continued expansion of behavioral health services.
  • Operational efficiencies expected to improve margins.
  • Projected EPS-diluted range of $18.45 to $19.95.

Headwinds

  • Higher labor costs could impact margins.
  • Potential reimbursement pressures from Medicare and Medicaid changes.
  • Regulatory risks in key operating regions.
  • Increased interest expenses due to debt levels.
  • Continued competitive pressures in the healthcare sector.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2024

Historical avgQ4 2024

+0.3%

Avg return

Earnings day

+0.3%

Avg return

5 days after

+0.7%

Avg return

30 days after

49%

34 / 69 earnings

Positive

+17.5%

Q3 2022

Best reaction

-13.4%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-9.5%-7.0%-16.4%
Q4 2025-5.5%-1.0%-9.9%
Q3 2025+2.5%+1.4%+14.1%
Q2 2025-0.2%+3.3%+7.3%
Q1 2025-0.6%+3.4%+10.5%
Q4 2024+3.3%-3.8%+3.4%
Q3 2024-13.4%-12.1%-15.5%
Q2 2024+10.6%+17.3%+25.8%
Q1 2024+0.1%+2.6%+6.9%
Q4 2023-1.6%+4.1%+11.0%
Q3 2023-0.2%-0.6%+11.4%
Q2 2023-4.6%-6.5%-12.3%
Q1 2023+1.5%+6.9%-9.3%
Q4 2022-9.1%-13.5%-15.5%
Q3 2022+17.5%+25.8%+39.3%
Q2 2022-1.5%+1.3%-5.7%
Q1 2022-5.7%-7.8%-8.1%
Q4 2021+8.6%+8.7%+11.1%
Q3 2021-7.0%-8.5%-5.0%
Q2 2021+4.2%+5.1%+1.6%
Q1 2021+0.3%+2.0%+10.1%
Q4 2020-9.1%-6.2%-2.0%
Q3 2020+3.0%+11.1%+24.2%
Q2 2020+0.9%+1.7%+0.2%
Q1 2020+3.7%-2.5%+8.6%
Q4 2019-5.3%-2.7%-34.3%
Q3 2019-4.6%-4.0%-3.6%
Q2 2019+10.9%+11.6%+4.7%
Q1 2019-0.8%-2.6%-5.5%
Q4 2018+3.9%+2.7%+0.1%
Q3 2018-5.3%-1.0%+8.0%
Q2 2018+9.3%+9.3%+12.0%
Q1 2018-4.6%-5.2%-3.2%
Q4 2017-1.3%+5.3%+0.7%
Q3 2017-6.9%-8.3%-9.9%
Q2 2017-9.2%-10.3%-12.6%
Q1 2017-2.0%-0.1%-3.0%
Q4 2016-0.9%-0.8%-0.8%
Q3 2016+0.6%-0.7%+1.3%
Q2 2016-4.4%-5.2%-12.1%
Q1 2016+2.1%
Q4 2015+2.4%
Q3 2015+2.4%
Q2 2015+2.1%
Q1 2015-0.7%
Q4 2014+3.8%
Q3 2014-1.0%
Q2 2014+6.8%
Q1 2014+8.3%
Q4 2013-2.6%
Q3 2013+2.6%
Q2 2013+3.3%
Q1 2013+3.3%
Q4 2012-0.0%
Q3 2012-3.2%
Q2 2012+4.8%
Q1 2012-1.7%
Q2 2011+2.0%
Q4 2011+2.0%
Q3 2011+3.8%
Q1 2010+3.8%
Q4 2010+3.8%
Q1 2011+3.8%
Q2 2010+5.0%
Q3 2009+0.0%
Q3 2010+0.0%
Q4 2009-0.3%
Q2 2009-0.3%
Q4 2008-0.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro